Canada Life’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.43M | Hold |
140,778
| – | – | ﹤0.01% | 1121 |
|
|
2026
Q1 | $1.75M | Buy |
140,778
+128,174
| +1,017% | +$1.72M | ﹤0.01% | 1192 |
|
|
2025
Q4 | $159K | Hold |
12,604
| – | – | ﹤0.01% | 1655 |
|
|
2025
Q3 | $124K | Hold |
12,604
| – | – | ﹤0.01% | 1737 |
|
|
2025
Q2 | $102K | Sell |
12,604
-42,134
| -77% | -$318K | ﹤0.01% | 1765 |
|
|
2025
Q1 | $459K | Hold |
54,738
| – | – | ﹤0.01% | 1627 |
|
|
2024
Q4 | $433K | Hold |
54,738
| – | – | ﹤0.01% | 1666 |
|
|
2024
Q3 | $456K | Hold |
54,738
| – | – | ﹤0.01% | 1690 |
|
|
2024
Q2 | $348K | Buy |
54,738
+18,632
| +52% | +$118K | ﹤0.01% | 1755 |
|
|
2024
Q1 | $218K | Buy |
36,106
+29,133
| +418% | +$164K | ﹤0.01% | 1821 |
|
|
2023
Q4 | $42K | Buy |
+6,973
| New | +$31.1K | ﹤0.01% | 2057 |
|
|
2023
Q2 | – | Sell |
-7,150
| Closed | -$10K | – | 2263 |
|
|
2023
Q1 | $10K | Hold |
7,150
| – | – | ﹤0.01% | 2295 |
|
|
2022
Q4 | $14K | Hold |
7,150
| – | – | ﹤0.01% | 2306 |
|
|
2022
Q3 | $14K | Hold |
7,150
| – | – | ﹤0.01% | 2305 |
|
|
2022
Q2 | $23K | Hold |
7,150
| – | – | ﹤0.01% | 2235 |
|
|
2022
Q1 | $32K | Hold |
7,150
| – | – | ﹤0.01% | 2261 |
|
|
2021
Q4 | $34K | Hold |
7,150
| – | – | ﹤0.01% | 2273 |
|
|
2021
Q3 | $38K | Hold |
7,150
| – | – | ﹤0.01% | 2297 |
|
|
2021
Q2 | $37K | Hold |
7,150
| – | – | ﹤0.01% | 2351 |
|
|
2021
Q1 | $48K | Hold |
7,150
| – | – | ﹤0.01% | 2305 |
|
|
2020
Q4 | $33K | Hold |
7,150
| – | – | ﹤0.01% | 2415 |
|
|
2020
Q3 | $28K | Hold |
7,150
| – | – | ﹤0.01% | 2343 |
|
|
2020
Q2 | $34K | Hold |
7,150
| – | – | ﹤0.01% | 2356 |
|
|
2020
Q1 | $25K | Hold |
7,150
| – | – | ﹤0.01% | 2325 |
|
|
2019
Q4 | $34K | Buy |
+7,150
| New | +$24.9K | ﹤0.01% | 2386 |
|
|
2019
Q3 | – | Sell |
-13,475
| Closed | -$96K | – | 1166 |
|
|
2019
Q2 | $96K | Buy |
13,475
+8,880
| +193% | +$90.8K | ﹤0.01% | 2240 |
|
|
2019
Q1 | $65K | Hold |
4,595
| – | – | ﹤0.01% | 2194 |
|
|
2018
Q4 | $60K | Sell |
4,595
-8,374
| -65% | -$151K | ﹤0.01% | 2306 |
|
|
2018
Q3 | $288K | Buy |
12,969
+5,033
| +63% | +$106K | ﹤0.01% | 1887 |
|
|
2018
Q2 | $130K | Buy |
+7,936
| New | +$139K | ﹤0.01% | 2104 |
|
Other funds holding AMRX
TGA
RCMNY
Canada Life's AMRX Position: Q2 2026 in Review
Canada Life held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 140,778 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1121.
Canada Life first reported a position in AMRX in Q2 2018 and has held it in 30 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.
- Canada Life held 140,778 shares of Amneal Pharmaceuticals worth $2.43M as of Q2 2026.
- Canada Life left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
- Amneal Pharmaceuticals made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1121 holding.
- Canada Life first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 30 quarters since.
- 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.
Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.